IMPROVING VTE RISK ASSESSMENT IN HOSPITALISED PATIENTS IN A TERTIARY CARE HOSPITAL IN IRELAND
DOI:
https://doi.org/10.55519/JAMC-01-13044Keywords:
Venous thromboembolism, hospital acquired thrombosis, multimodal intervention, PDSA, education, thromboprophylaxis, multidisciplinary team, Ireland.Abstract
Background: The initial baseline audit showed that only 24% of patients had a documented VTE- RA, this demonstrated an urgent need to improve VTE-RA in hospitalised patients. This quality improvement project (QIP) aimed to achieve 90% compliance in completing the VTE-RA tool and embedding this process into practice. Several measures were carried out which included the development of a TP policy, VTE-RA tool, education sessions and monthly point prevalence audits incorporating Plan, Do, Study, Act (PDSA) cycles. A follow-up audit was conducted one-year post-implementation using the same methodology as the baseline. Methods: This was a single centre before-after study, using a prospective cross-sectional design for both the baseline and post-intervention studies in a tertiary referral hospital in Cork, Ireland. All adult inpatients (>18 years) were eligible for inclusion. Documented evidence of VTE-RA and a prescription of TP were recorded. Results: The follow-up audit showed significant (p <0.001) improvement in documentation of VTE-RA from 24% (244/1019) to 57% (612/1070) and the prescription of pharmacological TP increased significantly (p<0.001) from 43% (441/1019) to 67% (713/1070). This improvement in VTE-RA was highest in patients with an increased risk of thrombosis from 21.9% (n=180/819) to 61% (n=493/807). Conclusion: The introduction of a TP policy and VTE-RA tool increased compliance by 33%. However, without a dedicated multidisciplinary “thrombosis team” to actively implement this, the achievements to date are unsustainable and attaining 90% compliance with VTE-RA is unlikely.References
Cohen AT, Agnelli G, Anderson FA, Arcelus JI, Berggvist D, Brecht JG, Greer IA, Heit JA, Hutchinson JL, Kakkar AK, Mottier D, Oger E, Samama MM,Spannagl M. VTE impact assessment group in Europe, Venous thromboembolism (VTE) in Europe. The number of VTE events and associated morbidity and mortality. Thromb Haemost 2007;98:756-64
Sweetland S, Green J,Liu B, Berrington de Gongalez A, Canonico M, Reeves G, Beral V. Duration and magnitude of the postoperative risk of venous thromboembolism in middle aged women: prospective cohort study. BMJ 2009; Dec 3:339:b4583. doi: 10.1136/bmj.b4583
Hunt BJ. The prevention of hospital-acquired venous thromboembolism in the United Kingdom.: review. Br J Haematol 2009Mar;144(5):642-652
Guyatt GH, Akl EA, Crowther M, et al. Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 2012; Feb;141(2 Suppl):7S-47S. doi: 10.1378/chest.1412S3.
Anderson FA Jr, Zayaruzny M, Heit JA, et al. Estimated annual numbers of US acute-care hospital patients at risk for venous thromboembolism. Am J Hematol 2007;82:777-82.
Clagett GP, Anderson Jr FA, Levine MN, Salzman EW, Wheeler HB. Prevention of VTE. Chest 1992; Oct;102(4 Suppl):391S-407S. doi: 10.1378/chest.102.4_supplement.391s.
Cohen AT, Tapson VF, Rodger MA, Bergmann JF, Goldhaber SZ, Kakkar AK, Deslandes B, Huang W, Zayaruzny M, Emery L, Anderson FA Jr: ENDORSE Investigators. Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study. Lancet 2008;371:387-94.
Jha, AK; Larizgoitia I; Audera-Lopez, C; Prasopa-Plaizier, N; Waters, H; Bates, DW. The global burden of unsafe medical care: analytic modelling of observational studies. BMJ Qual Saf 2013; 22: 809-15.
Catterick D and Hunt BJ. Impact of the national venous thromboembolism risk assessment tool in secondary care in England: retrospective population-based database study. Blood Coagulation and Fibrinolysis 2014, Sep;25(6):571-6. doi: 10.1097/MBC.0000000000000100.25
Clinical guideline [CG92]Published: 27 January 2010 Last updated: 01 June 2015
NHSChoices.http:/www.nhs.uk/NHSEngland/thenhs/about/Pages/authoritiesandtrusts.aspx (accessed 21 May 2014).
Khan MI, O’Leary C, Silvary V, O’Brien A, Duggan C, O’Shea S. Current Practice of Hospital Acquired Thrombosis (HAT) Prevention in an Acute Hospital (a single centre cross sectional study. Ir Med J. 2017 Apr 10;110(4):547.
Khan MI, O’Leary C, Silvari V, O’Brien A, O’Connor M, Duggan C, O’Shea S. Incidence of Hospital Acquired Thrombosis (HAT) in a Tertiary Care Hospital. Ir Med J. 2017 Apr 10;110(4):542.
Khan MI, O’Leary C, Silvari V, O’Brien A, O’Connor M, Duggan C, O’Shea S. Venous Thromboembolism- Risk Assessment Tool and Thromboprophylaxis Policy: A National Survey: Irish Medical Journal January 2017, Volume 110; Number 1.
Goldhaber SZ, Leizorovicz A, Kakkar AK, et al. Apixaban versus Enoxaparin for thromboprophylaxis in medically ill patients. N Eng J Med 2011;365:2167-77.
Lederle FA, Zylla D, MacDonald R, et al. Venous thromboembolism prophylaxis is hospitalized medical patients and those with stroke: a background review for an American College of Physicians Clinical Practice Guideline. Ann Intern Med 2011;155:602-15.
Scaglione L, Piobbici M, Pagano E, et al. Implementing guidelines for venous thromboembolism prophylaxis in a large Italian teaching hospital: lights and shadows. Haematologica 2005;90:678-84.
Collins R, Mac Lellan L, Gibbs H, MacLellan D, Flecthcer J. Venous Thromembolism Prophylaxis: The role of the nurse in changing practice and saving lives (2009). Australian Journal of Advanced Nursing 27(3)
Gibbs H, Fletcher J, Blombery P, Collins R, Wheatley D. Venous thromboembolism prophylaxis guidelines implementation is improved by nurse directed feedback and audit (2011). Thrombosis Journal 9(7).
"Safermeds". VTE Improvement Collaborative. 2016. http://vteireland.org/
"Thrombosis Ireland". Thrombosisireland.ie. 2016. Web. 20 June 2017. info@thrombosisireland.ie
Additional Files
Published
Issue
Section
License
Copyright (c) 2024 Muhammad Irfan Khan, Aisling O’Brien, Catriona O’Leary, Virginia Silvari, Cleona Duggan, Susan O’Shea
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
Journal of Ayub Medical College, Abbottabad is an OPEN ACCESS JOURNAL which means that all content is FREELY available without charge to all users whether registered with the journal or not. The work published by J Ayub Med Coll Abbottabad is licensed and distributed under the creative commons License CC BY ND Attribution-NoDerivs. Material printed in this journal is OPEN to access, and are FREE for use in academic and research work with proper citation. J Ayub Med Coll Abbottabad accepts only original material for publication with the understanding that except for abstracts, no part of the data has been published or will be submitted for publication elsewhere before appearing in J Ayub Med Coll Abbottabad. The Editorial Board of J Ayub Med Coll Abbottabad makes every effort to ensure the accuracy and authenticity of material printed in J Ayub Med Coll Abbottabad. However, conclusions and statements expressed are views of the authors and do not reflect the opinion/policy of J Ayub Med Coll Abbottabad or the Editorial Board.
USERS are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles, or use them for any other lawful purpose, without asking prior permission from the publisher or the author. This is in accordance with the BOAI definition of open access.
AUTHORS retain the rights of free downloading/unlimited e-print of full text and sharing/disseminating the article without any restriction, by any means including twitter, scholarly collaboration networks such as ResearchGate, Academia.eu, and social media sites such as Twitter, LinkedIn, Google Scholar and any other professional or academic networking site.
